Dr. Domínguez-González

is a neurologist specializing in neuromuscular and mitochondrial diseases. She leads a multidisciplinary clinical and research group at University Hospital 12 de Octubre in Madrid, Spain, where she has worked in the Neuromuscular Unit since 2004. The unit is a National Reference Center for rare neuromuscular and mitochondrial disorders.

Her expertise focuses on genetic myopathies, particularly those of metabolic and mitochondrial origin. In 2020, she obtained her PhD from Complutense University of Madrid, with a doctoral thesis focused on the treatment of TK2 deficiency using non-GMP nucleosides.

Dr. Domínguez-González is a principal investigator at the i+12 Research Institute and has led multiple research projects and clinical trials. She has authored over 120 scientific publications, including 15 publications on TK2 deficiency. Her research interests include clinic-molecular characterization of mitochondrial diseases, biomarker validation, and the use of quantitative muscle MRI in mitochondrial myopathies.